Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 7Uterine Cervical Dysplasia 5Papillomavirus Infections 5Precancerous Conditions 3Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Spondylarthritis 1Ovarian Neoplasms 1Neoplasms 1Endometrial Neoplasms 1Atypical Squamous Cells of the Cervix 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Vaginal Smears × Clear all
NCT04859530 2025-01-29

Automated Cervical Cancer Screening Using a Smartphone-based Artificial Intelligence Classifier

University Hospital, Geneva

Phase NA Recruiting
5,886 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡